Syneos Health: Q4 Earnings Insights

 

Shares of Syneos Health SYNH remained unaffected after the company reported Q4 results.

Quarterly Results

Earnings per share rose 7.77% year over year to $1.11, which beat the estimate of $1.10.

Revenue of $1,140,000,000 decreased by 6.02% year over year, which were in line with the estimate of $1,140,000,000.

Outlook

The upcoming fiscal year's EPS expected to be between $4.09 and $4.38.

The upcoming fiscal year's revenue expected to be between $5,125,000,000 and $5,325,000,000.

How To Listen To The Conference Call

Date: Feb 18, 2021

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/h8kqo86z

Recent Stock Performance

Company's 52-week high was at $81.35

Company's 52-week low was at $30.02

Price action over last quarter: Up 47.21%

Company Overview

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Posted In: EarningsNewsBZI-Recaps
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...